早期类风湿关节炎达标治疗中患者报告结局数据的解读
本研究基于Care in Early RA随机对照试验,纳入333例早期RA患者,分析快速持续疾病控制(DAS28-CRP<2.6)对1年时SF-36和IPQ-R心理社会结局的影响。结果显示,早期持续应答者活力更高、对疾病后果和治疗效果信念更积极,治疗类型无关;基线心理社会变量解释力最大。
要点
- 早期持续疾病控制与1年时更好的活力和疾病感知相关。
- 治疗类型不影响患者报告的心理社会结局。
- 基线心理社会变量对结局变异的解释力最大。
核心结论
- 快速持续疾病控制而非治疗类型与1年时有利的患者报告健康和疾病感知相关,但基线心理社会变量最重要。
研究设计与样本
- Care in Early RA试验为前瞻性、2年、研究者发起的随机对照试验,植根于日常实践并实施达标治疗原则。
- 共333例患者纳入主要分析,其中140例为早期持续应答者。
- 基于第一年内DAS28-CRP<2.6的反应速度和一致性定义4种临床应答特征。
主要发现
- 早期持续应答者报告显著更高的活力、对疾病后果和治疗效果更积极的信念。
- 治疗类型对心理社会结局无影响。
- 1年时每个心理社会结局的变异主要由基线值解释,其次为临床应答特征。
关键数值与推荐
- 临床应答特征基于第一年内DAS28-CRP<2.6的反应速度和一致性定义。
- 采用线性回归分析预测SF-36的活力、社会功能、角色情感和心理健康维度及IPQ-R的后果、治疗控制和疾病连贯性子量表。
临床怎么用
- 在早期RA达标治疗中,关注快速且持续的疾病控制可能改善患者报告的健康和疾病感知。
- 基线心理社会因素对结局影响最大,临床中应重视评估和干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Treating early, intensively, and to target leads to rapid disease control, preventing joint damage and loss of function in early rheumatoid arthritis (RA). We report the effect of such an approach on patient-reported outcomes and explore the contribution of rapid and persistent disease control to well-being after 1 year of treatment. METHODS: This study is part of the Care in Early RA trial, a prospective, 2-year, investigator-initiated, randomized controlled trial rooted in daily practice and implementing the treat-to-target principle. Short Form 36 (SF-36) health survey and Revised Illness Perception Questionnaire (IPQ-R) data were collected prospectively. We defined 4 clinical response profiles based on speed and consistency of the treatment response within the first year, defined as the Disease Activity Score in 28 joints using the C-reactive protein level <2.6. Linear regression analyses including these response profiles and treatment type were constructed to predict the SF-36 dimensions of vitality, social functioning, role emotional, and mental health, and the IPQ-R illness perception subscales of consequences, treatment control, and illness coherence at year 1. RESULTS: A total of 333 patients were available for the main analyses, including 140 early persistent responders. Variation in each of the psychosocial outcomes at year 1 was explained mostly by baseline values, followed by the clinical response profiles. Patients with an early persistent response reported significantly higher vitality, more positive beliefs about disease consequences and treatment effect. Treatment type did not matter. CONCLUSION: Rapid and persistent disease control and not treatment type were associated with favorable patient-reported health and illness perceptions at year 1, but baseline psychosocial variables mattered most. Our data indicate opportunities to broaden the scope of the treat-to-target principle in early RA.
引用
- Van der Elst K, Verschueren P, Stouten V, et al. Patient-Reported Outcome Data From an Early Rheumatoid Arthritis Trial: Opportunities for Broadening the Scope of Treating to Target. Arthritis Care Res (Hoboken). 2019. PMID: 30951267. doi:10.1002/acr.23900
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。